Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 3/2021

Content (25 Articles)

Breast Cancer editorial

Best of SABCS 2020

Marija Balic

Open Access Breast Cancer short review

Post San Antonio update—my top three abstracts!

Christoph Suppan

Breast Cancer short review

Top 3 abstracts concerning hormone-receptor-positive early breast cancer

Simon Peter Gampenrieder, Gabriel Rinnerthaler, Richard Greil

Glioma short review

Innovative therapy concepts for pediatric brain tumors

Amedeo A. Azizi, Johannes Gojo, Andreas Peyrl

Primary diffuse leptomeningeal melanomatosis: report of three pediatric cases and review of the literature

Giovanna Pezzullo, Lorenzo Ugga, Renato Cuocolo, Teresa Perillo, Alessandra D’Amico

short review

Rehabilitation for children and adolescents after cancer: importance and implementation in Austria

Gustav Fischmeister, David Riedl, Gabriele Sanio, Thomas Bogendorfer, Bernhard Holzner, Gerhard Rumpold, Alain Nickels, Thomas Licht, Wolfgang Sperl

Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis

Josia Fauser, Stefan Köck, Eberhard Gunsilius, Andreas Chott, Andreas Peer, Adelheid Ditlbacher, Gernot Fritsche, Michael Joannidis, Dominik Wolf, Andreas Pircher

Amphotericin B case report

Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review

Anis Chaari, Esraa Turak, Mark Nashaat, Islam Aboayana, Vipin Kauts

Open Access osteosarcoma short review

Novel agents in a young patient with osteosarcoma: A short review

Oskar Steinbrecher, Thomas Brodowicz, Wolfgang Lamm

A patient with liver cirrhosis and hepatic lesions

Tobias Meischl, Dietmar Tamandl, Matthias Pinter

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine